ES
INNOVATING
FOR HEALTH

TECHNOLOGY

On many occasions, the clinical efficacy of topical treatments is erratic and unpredictable due to the ease removal of the conventional formulations (creams and ointments) from the site of application by sweating, humidity or cloths friction. In order to avoid this situation, the medical practice recommends the use of dressings to cover the treated area which may result in skin maceration and alteration of the protective epidermis balance, modifying the safety and efficacy of dermatological treatments.

Ojer Pharma has developed an innovative vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatological actives (lipophilics and hydrophilics). This technology has been successfully applied to three of the five dermatological molecules best selling worldwide and has been adequately protected by international patents.


PATENTS

The important technological advantages have been adequately
protected by international patents

WO 2012/052472 A1
WO 2014/095705 A1

REQUESTED IN PROCESS GRANTED
AMERICA 03 02 03
EUROPE 00 00 09
AFRICA 00 00 02
ASIA 05 03 03
OCEANIA 01 01 02